Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | Genetic profiling: the key to Huntington’s treatment?

Lesley Jones • 20 Mar 2019
ARUK 2019
Huntington’s Disease Movement Disorders

Lesley Jones, PhD, of Cardiff University, Cardiff, UK, discusses how the genetic profiling of patients with Huntington’s disease can be used to create pharmaceutical treatments for the disease. Prof. Jones also goes on to discuss cutting-edge clinical trials taking place that are seeking good therapeutic outcomes for patients. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK.

More from Lesley Jones

FAN1 modifies Huntington’s disease progression
5:03
FAN1 modifies Huntington’s disease progression
Lesley Jones • 20 Mar 2019
Neurogenetics of Huntington’s disease onset
1:30
Neurogenetics of Huntington’s disease onset
Lesley Jones • 20 Mar 2019

Related Videos

Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
3:18
Findings from the Phase III FoCus trial: tiomolibdate choline for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Current treatment and unmet needs in neurologic Wilson's disease
3:15
Current treatment and unmet needs in neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Emerging therapies for neurologic Wilson's disease
2:42
Emerging therapies for neurologic Wilson's disease
Aurelia Poujois • 29 Jun 2026
Guidance for clinicians on the real-world use of foslevodopa/foscarbidopa for PD
7:39
Guidance for clinicians on the real-world use of foslevodopa/foscarbidopa for PD
K. Ray Chaudhuri • 30 Jun 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals